Status:

COMPLETED

Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting

Lead Sponsor:

Medstar Health Research Institute

Conditions:

Complication of Coronary Artery Bypass Graft

Peri-operative Hemorrhage or Hematoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary objective of this exploratory cohort study is to describe levels of platelet reactivity in patients on a thienopyridine awaiting coronary artery bypass grafting (CABG).

Detailed Description

The recent emergence of platelet reactivity testing as a potential option for evaluating the degree of platelet inhibition promises to add another level of understanding to our concept of CABG-related...

Eligibility Criteria

Inclusion

  • Patients ≥ 18 years old from both genders.
  • Taking maintenance thienopyridine therapy within 5 days of surgery OR received a loading dose of thienopyridine therapy within 48 hours of surgery for CABG.
  • Referred for CABG (which is scheduled to be performed during the current admission).

Exclusion

  • Known allergies to aspirin, clopidogrel, or prasugrel.
  • Use of a glycoprotein (GP) IIb/IIIa inhibitor within 8 hours of initial platelet reactivity testing.
  • Patient known to be pregnant or lactating.
  • Patient with known history of bleeding diathesis or currently active bleeding.
  • Platelet count \<100,000/mm the day of initial blood draw.
  • Hematocrit \<25% the day of initial blood draw.
  • On warfarin therapy at the time of initial blood draw.
  • Known blood transfusion within the preceding 10 days of the blood draw.
  • Patients treated with non-steroidal anti-inflammatory drugs (NSAIDS) within the previous 5 days.
  • Plan for patient to be discharged before undergoing CABG.
  • Any significant medical condition that, in the investigator's opinion, may interfere with the patient's optimal participation in the study.

Key Trial Info

Start Date :

August 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2016

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT01406483

Start Date

August 1 2010

End Date

July 1 2016

Last Update

March 16 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting | DecenTrialz